Success Metrics

Clinical Success Rate

62.5%

Based on 5 completed trials

Completion Rate

63%(5/8)

Active Trials

7(41%)

Results Posted

0%(0 trials)

Terminated

3(18%)

Phase Distribution

Ph phase_3

71%

Ph phase_1

18%

Ph phase_2

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution17 total trials

Phase 1Safety & dosage

3(17.6%)

Phase 2Efficacy & side effects

1(5.9%)

Phase 3Large-scale testing

12(70.6%)

Phase 4Post-market surveillance

1(5.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(9)

Completed(5)

Terminated(3)

Detailed Status

Recruiting7

Completed5

Terminated3

Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

62.5%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (17.6%)

Phase 21 (5.9%)

Phase 312 (70.6%)

Phase 41 (5.9%)

Trials by Status

completed529%

recruiting741%

not_yet_recruiting212%

terminated318%

Recent Activity

7 active trials

Showing 5 of 17

not_yet_recruitingphase_3

CiLostAzol for pReventIon of Recurrent sTroke in Africa

NCT06919835

completedphase_2

The Effect of Cilostazol on Rheumatoid Arthritis Patients

NCT05671497

recruitingphase_3

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

NCT06591377

not_yet_recruitingphase_3

Cilostazol for Prevention of Recurrent Stroke Trial

NCT07174414

terminatedphase_3

Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication

NCT06886620

View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials

NCT06919835Phase 3

CiLostAzol for pReventIon of Recurrent sTroke in Africa

Not Yet Recruiting

NCT05671497Phase 2

The Effect of Cilostazol on Rheumatoid Arthritis Patients

Completed

NCT06591377Phase 3

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Recruiting

NCT07174414Phase 3

Cilostazol for Prevention of Recurrent Stroke Trial

Not Yet Recruiting

NCT06886620Phase 3

Assess the Safety and Effectiveness of Once Daily PMR Compared to Twice Daily Pletaal® in Patients With Intermittent Claudication

Terminated

NCT05191862Phase 1

Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers

Terminated

NCT06591299Phase 3

Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

Recruiting

NCT06591390Phase 3

Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA

Recruiting

NCT06591351Phase 3

Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA

Recruiting

NCT06242132Phase 3

Clopidogrel Versus Cilostazol in Ischemic Stroke

Completed

NCT06202755Phase 3

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Recruiting

NCT06196047Phase 3

Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA

Recruiting

NCT06242145Phase 3

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

Completed

NCT06561867Phase 3

Ticagrelor Versus Cilostazol in Ischemic Stroke

Recruiting

NCT04148105Phase 4

Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)

Terminated

NCT03864666Phase 1

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Completed

NCT03480321Phase 1

Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Completed

All 17 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 17